ArticleExperimental hematology & oncology2022

Rituximab, lenalidomide and BTK inhibitor as frontline treatment for elderly or unfit patients with diffuse large B-cell lymphoma: a real-world analysis of single center.

Yanan Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.